复发性口腔口炎,氧化应激和缺血改性白蛋白:一个横截面研究
Aynure Öztekin1, Coşkun Öztekin2, Hümeyra Nursel Şahin3
1Department of Dermatology, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.
Medicine
|July 23, 2025
概括
在患有复发性口腔口炎的患者中,缺血变异性白蛋白 (IMA) 的水平显着更高,这表明它有可能作为与氧化应激相关的这种疾病的诊断标志物.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 口腔医学是指口腔医学.
背景情况:
- 复发性口腔口腔炎 (RAS) 是一种炎症性口腔疾病,导致疼痛的.
- RAS的确切原因尚不清楚,但氧化应激与其发病有关.
- 氧化应激会破坏亲氧化和抗氧化物质之间的平衡.
研究的目的:
- 为了比较RAS患者与健康对照者的缺血修饰性白蛋白 (IMA) 水平.
- 评估IMA作为RAS的潜在生物标志物的诊断价值.
主要方法:
- 一项涉及32名RAS患者和34名健康志愿者的横截面研究.
- 在静脉血液样本中,使用阿尔伯明结合试验分析了阿尔伯明和IMA水平.
- 采用接收器操作特征 (ROC) 分析来评估IMA的诊断能力.
主要成果:
- 与健康对照组相比,RAS患者组的IMA水平显著升高 (P < .001).
- 国际药物管理协会 (IMA) 证明了在确定复发性口腔口炎 (P < .001) 时具有统计学上显著的预测价值.
- 在ROC曲线下的面积表明IMA (0.952) 的区分能力非常好.
结论:
- 升高的IMA水平与反复复发的口腔口炎密切相关.
- IMA可以作为RAS中氧化应激的有价值的诊断指标.
- 这些发现突出了氧化应激在RAS病变发生过程中的作用.
相关概念视频
Coronary Artery Disease II: Pathophysiology
39
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
39
Atherosclerosis I: Introduction
89
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
89
Coronary Artery Disease I: Introduction
59
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
59
Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36


